High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients

Author： Valgimigli Marco   Percoco Gianfranco   Cicchitelli Giordano   Ferrari Fabrizio   Barbieri Dario   Ansani Lucia   Guardigli Gabriele   Parrinello Giovanni   Malagutti Patrizia   Soukhomovskaia Olga   Bettini Alessandro   Campo Gianluca   Ferrari Roberto  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.3, 2004-05, pp. : 225-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus-eluting stent favourable vs bare-metal stent in STEMI

By  

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior to bare-metal stent in MI

By  

Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Sirolimus: Thrombosis and myocardial infarction associated with a drug-eluting stent: case report

By  

Reactions Weekly, Vol. 1, Iss. 1083, 2006-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

ORAR III study investigators say that a bare metal stent (BMS) plus oral sirolimus provides a comparable, cost-effective alternative to a drug-eluting stent

By  

Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus: Stent thrombosis in a patient with a drug-eluting and bare-metal stent?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1214, 2008-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite